Gastroenterology

Investigators have found that many autoimmune diseases are implicated in the surge and development of eating disorders, according to a study published in PLoS One.

Neon feces could prove to be a game changer in gastrointestinal cancer testing. Researchers at McMaster University, Hamilton, Ontario, Canada, are developing a new non-invasive stool exam to identify the presence of colorectal cancer.

The anion gap is extremely useful in the detection and analysis of metabolic acidosis and also intoxicants and some hematologic conditions.

The United Kingdom's National Institute for Health and Care Excellence (NICE) is recommending Sovaldi as a cost-effective option to treat some people who have chronic hepatitis C.

Between developing its own pipeline of therapies for patients with hepatitis C and acquiring another company known for its work in this field, it looks like Merck is taking steps to be a larger player in HCV market.

An emerging epidemic of acute hepatitis C threatens the country's younger population, which experienced a significant hike in the number of cases during a recent 6-year period, according to a compound study that looked at trends of the disease among youth.

Abuse-deterrent properties, identical efficacy for pain relief, reversal of opioid-induced constipation, and theoretical tolerance mitigation may give Targiniq ER an interesting advantage over other oral opioids.

Crops raised in a method that meets the organic standard contain more antioxidants than traditionally grown crops. Nevertheless, it remains unproven whether diets with higher antioxidant concentrations provide improved health outcomes.

Agent Orange exposure several decades earlier may increase morbidity from various diseases, some of which have rarely been explored in previous epidemiologic studies.

Those who have lost a significant amount of weight are often left with sagging skin, and exercise is not the solution to that problem.

Although small-bowel capsule endoscopy is often used to evaluate unexplained abdominal pain, a new analysis has found the procedure's diagnostic yield is limited.

When gallstones are the source of acute pancreatitis, the condition can be life threatening.

Researchers at Wake Forest Baptist Medical Center have released a study showing the potential of a dangerous interaction between a common supplement and prescription medication.

A new pill could be the next tool in a patient's fight to lose weight, according to a recent study.

The US Food and Drug Administration partially lifted a clinical hold on a hepatitis C drug under development by Achillion Pharmaceuticals, clearing the way for a restart of the company's clinical trials of sovaprevir.

Prebiotics and probiotics have been discussed frequently in the media for supposedly improving overall health, especially diseases related to the gut. However, the evidence on the efficacy and use of these dietary supplements is rather complicated.

Barrett's esophagus is frequently overdiagnosed in clinical settings, which has broad implications for patient health, medical costs, and psychological stress due to perceived cancer risk.

Incorporating aspects of the small particle diet into the recommendations for diabetic gastroparesis might be beneficial to patients.

Patients with celiac disease treated with larazotide acetate experienced improvements in GI symptoms and non-GI symptoms such as headache and fatigue, as well as significant reductions in the number of symptomatic days.

Though constipation as a side effect of opioid therapy is generally considered a tolerability issue that can be treated with over-the-counter laxatives, opioid-induced constipation may still lead to serious gastrointestinal complications.

A multipronged approach built around screening, education, community outreach, and expanded access to care is critical to reducing the prevalence of hepatitis C in the African-American community.

Although they are revolutionary for the treatment of various gastric acid-related disorders, proton pump inhibitors may be linked to interstitial nephritis, according to research published in Kidney International.

Company is seeking FDA approval for its all-oral, interferon-free regimen for the treatment of adult patients with chronic genotype 1 hepatitis C.

New guidance from the WHO includes nine key recommendations covering screening, treatment, alcohol use assessment and counseling, and measures to prevent transmission of the virus.

SAPPHIRE II trial results show sustained virologic response in 96% of treatment-experienced patients with genotype 1 hepatitis C who were treated with interferon-free, triple-drug regimen.